Ross LL, Robinson MD, Carosi G, Lazzarin A, Stellbrink H-J, Moyle G, Givens N, Nichols WG. Impact of HIV subtype on response and resistance in antiretroviral-naïve adults comparing treatment with once daily versus twice daily ritonavir boosted fosamprenavir in combination with Abacavir/Lamivudine. Drugs Ther Studies [Internet]. 2011 Dec. 30 [cited 2024 Apr. 26];2(1):e1. Available from: https://www.pagepress.org/journals/dts/article/view/dts.2012.e1